Author

Michael S. Frontiera

Observed names: M FRONTIERA, M Frontiera, M. Frontiera, M. S. Frontiera, M.S. Frontiera, Michael Frontiera

Institution: Dean Health Systems

Observed institutions: National Institutes of Health, University of Wisconsin System, University of Wisconsin–Madison, Meriter Hospital, University of Colorado Health, Saint Vincent's Catholic Medical Center, Asheville Hematology & Oncology, University of Wisconsin Carbone Cancer Center, Dana-Farber Cancer Institute, Dean Health Systems, University of Pennsylvania, University of Colorado Denver

OpenAlex ID: A5065989656

Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089

2005 · Daniel G. Haller, Paul J. Catalano, et al. · Journal of Clinical Oncology · 398

Regulation of methionine metabolism: Effects of nitrous oxide and excess dietary methionine

1994 · Michael S. Frontiera, Sally P. Stabler, et al. · The Journal of Nutritional Biochemistry · 52

Peripheral blood and bone marrow abnormalities in the acquired immunodeficiency syndrome.

1987 · M Frontiera, A M Myers · PubMed Central · 46

Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized Study

1992 · D. S. Ettinger, D. M. Finkelstein, et al. · JNCI Journal of the National Cancer Institute · 41

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

2011 · Adam Brufsky, Karen Hoelzer, et al. · Clinical Breast Cancer · 29

Randomized Phase II-III Trial of Combination Beta and Gamma Interferons and Etoposide and Cisplatin in Inoperable Non-Small Cell Cancer of the Lung

1989 · J. H. Schiller, B. Storer, et al. · JNCI Journal of the National Cancer Institute · 26

Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.

1991 · J Grem, P O'Dwyer, et al. · Journal of Clinical Oncology · 17

A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group.

1995 · J P Dutcher, T Leong, et al. · PubMed · 6

Sequential Use of lndium-111 Labeled Monoclonal Antibodies 96.5 and ZME-018 does not Increase Detection Sensitivity for Metastatic Melanoma

1989 · M FRONTIERA, J L MURRAY, et al. · Clinical Nuclear Medicine · 5

2006 · J.C. Landry, P. Catalano, et al. · International Journal of Radiation Oncology*Biology*Physics · 3

Works count: 10

Citation count: 623

H-index: 7

I10-index: 7